US Patent Issued to Recursion Pharmaceuticals on Dec. 9 for "Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictions" (American, Canadian Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,494,266, issued on Dec. 9, was assigned to Recursion Pharmaceuticals Inc. (Salt Lake City).

"Utilizing a clinical-phenomics causal discovery framework to generate causal discovery predictions" was invented by Hayley Jeton Donnella (Austin, Texas), Seyed Ali Madani Tonekaboni (Toronto) and William Paul Bone (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to systems, non-transitory computer-readable media, and methods that analyze gene perturbation machine learning embeddings and clinical observation data sets utilizing machine learning, explainability models, and causal discovery models to generate causal pred...